Alex Denner (Getty Images)

Two years af­ter a re­buffed ac­tivist at­tack, Alex Den­ner fi­nal­ly gets his seat on Iron­wood's board

Faced with an in­sur­gency from the ac­tivist in­vestor Alex Den­ner in 2018, Iron­wood Phar­ma­ceu­ti­cals mount­ed a vo­cal and ul­ti­mate­ly suc­cess­ful cam­paign to keep the for­mer Carl Ic­ahn pro­tégé off their board.

Now, two years lat­er and with the com­pa­ny fac­ing a re­struc­tur­ing and ma­jor ques­tions about its board, Iron­wood has is­sued a short and sur­pris­ing press re­lease: Alex Den­ner is join­ing the board.

“Iron­wood has de­vel­oped a strong re­la­tion­ship with Alex over these past few years, as Saris­sa has be­come one of our largest share­hold­ers,” Iron­wood said in an emailed state­ment.  “Alex knows Iron­wood well, and the Board be­lieves he brings to the com­pa­ny an im­por­tant share­hold­er per­spec­tive as well as broad health­care-in­dus­try knowl­edge and ex­pe­ri­ence as a board di­rec­tor in over­see­ing the op­er­a­tions of health­care com­pa­nies.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.